EP1530454A1 - Utilisation de derives de dicetopiperazines comme filtres uv photostables dans des preparations cosmetiques et pharmaceutiques - Google Patents

Utilisation de derives de dicetopiperazines comme filtres uv photostables dans des preparations cosmetiques et pharmaceutiques

Info

Publication number
EP1530454A1
EP1530454A1 EP03793639A EP03793639A EP1530454A1 EP 1530454 A1 EP1530454 A1 EP 1530454A1 EP 03793639 A EP03793639 A EP 03793639A EP 03793639 A EP03793639 A EP 03793639A EP 1530454 A1 EP1530454 A1 EP 1530454A1
Authority
EP
European Patent Office
Prior art keywords
cosmetic
piperazinedione
compounds
pharmaceutical preparations
benzylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03793639A
Other languages
German (de)
English (en)
Inventor
Thomas Heidenfelder
Kristin Tiefensee
Thomas Wünsch
Robert Parker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of EP1530454A1 publication Critical patent/EP1530454A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Definitions

  • the invention relates to the use of diketopiperazine derivatives as photostable UV filters in cosmetic and pharmaceutical preparations for protecting the human epidermis or human hair against UV radiation, especially in the range from 320 to 400 nm.
  • the light stabilizers used in cosmetic and pharmaceutical preparations have the task of preventing harmful effects of sunlight on human skin or at least reducing their effects. In addition, these light stabilizers also serve to protect other ingredients from destruction or degradation by UV radiation. In hair cosmetic formulations, damage to the keratin fiber by UV rays is to be reduced.
  • UV-B 280 to 320 nm
  • UV-A radiation > 320 nm
  • UV-A radiation can also cause skin damage and allergies, for example by damaging keratin or elastin. This reduces the skin's elasticity and water retention capacity, i.e. the skin becomes less supple and tends to wrinkle.
  • the strikingly high incidence of skin cancer in areas exposed to strong sunlight shows that damage to the genetic information in the cells is apparently caused by sunlight, especially by UV-A radiation. All of these findings therefore make the development of efficient filter substances for the UV-A range appear necessary.
  • light stabilizers for cosmetic and pharmaceutical preparations which can serve above all as UV-A filters and whose absorption maxima should therefore be in the range from approximately 320 to 380 nm.
  • such light stabilizers should additionally have a highly specific absorbance.
  • light stabilizers for cosmetic preparations have to meet a number of other requirements, for example good solubility in cosmetic oils, high stability of the emulsions prepared with them, toxicological harmlessness and low intrinsic odor and low intrinsic color.
  • UV-A filter 4- (1, 1-Dimethylethyl) -4 '-methoxydibenzoylmethan described as UV-A filter. It is proposed to combine this special UV-A filter, which is sold by the company GIVAUDAN under the name "PARSOL 1789", with various UV-B filters in order to obtain the total UV rays with a wavelength of 280 to 380 absorb nm.
  • UV-A filter when used alone or in combination with UV-B filters, is not photochemically stable enough to ensure lasting protection of the skin during long sunbathing, which means repeated use at regular and short intervals required if you want to achieve effective protection of the skin against all UV rays.
  • the insufficiently photostable UV-A filters are to be stabilized by the addition of 2-cyano-3,3-diphenyl-acrylic acid esters, which serve as filters even in the UV-B range.
  • the object was therefore to propose light stabilizers for cosmetic and pharmaceutical purposes which absorb in the UV-A range with high extinction and which are photostable, a small one Own color, ie a sharp band structure and, depending on the substituent, soluble in oil or water.
  • R 1 and R 2 can each independently be the same or different and are hydrogen or C 1 -C 4 alkyl and
  • R 3 , R 4 , R 5 , R 6 can each independently be the same or different and denote hydrogen, -CC alkyl or an aryl radical,
  • photostable UV filters in cosmetic and pharmaceutical preparations for protecting human skin or hair against sun rays, alone or together with compounds known per se for cosmetic and pharmaceutical preparations and absorbing in the UV range.
  • C 1 -C 4 -alkyl radicals are branched or unbranched C 1 -C 8 -alkyl chains, preferably methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1, 1-dimethyl - ethyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dryness ethylpropyl, 1-ethylpropyl, n-hexyl, 1, 1-dimethylpropyl, 1, 2-dimethylpropyl, 1-methylpentyl , 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1, 1-dryness thylbutyl, 1,2-di-ethylbutyl, 1, 3-drirne thylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl,
  • Aryl is to be understood as meaning aromatic rings or ring systems with 6 to 18 5 carbon atoms in the ring system, for example benzyl, phenyl or naphthyl, which may optionally contain one or more radicals such as halogen, for example fluorine, chlorine or bromine, cyano, nitro, amino, C ⁇ - -CC alkylamino, -CC -dialkylamino, hydroxy, C 1 -C 4 -AI- alkyl, -C-C 4 alkoxy or other radicals can be substituted. Substituted phenyl, methoxyphenyl, cyanophenyl and naphthyl are preferred.
  • Suitable alkoxy radicals are those having 1 to 4 carbon atoms.
  • Suitable mono- or dialkylamino radicals are those which contain 5 alkyl radicals with 1 to 12 carbon atoms, such as Methyl, n-propyl, n-butyl, 2-methylpropyl, 1, 1-dimethylpropyl, hexyl, heptyl, 2-ethylhexyl, isopropyl, 1-methylpropyl, n-pentyl, 3 -Methylbutyl-, 2, 2-dimethylpropyl-, 1-methyl-l-ethylpropyl- and octyl. 0
  • the compounds of formula I to be used according to the invention are known from the prior art (DE 39 18 178) and can be prepared, for example, according to the synthetic routes listed in EP 655 060 or according to J. Prakt. Chemie 1966, 32, 158-166 or J. Heterocyclic. Chem. 1988, 25, 591-597.
  • the present invention furthermore relates to cosmetic and pharmaceutical preparations which contain 0.1 to 10% by weight, preferably 1 to 7% by weight, based on the total amount of the cosmetic and pharmaceutical preparation, one or more of the compounds of the formula I. together with compounds known per se for cosmetic and pharmaceutical preparations and absorbing in the UV-A and UV-B range as light stabilizers, the compounds of the formula I generally in a smaller amount than the UV-B-absorbing compounds be used.
  • the cosmetic and pharmaceutical preparations containing light stabilizers are generally based on a carrier which contains at least one oil phase.
  • aqueous-based preparations alone are also possible when using compounds with hydrophilic substituents. Accordingly, oils, oil-in-water and water-in-oil emulsions, creams and pastes, lip protection stick compositions or grease-free gels are suitable.
  • the emulsions include O / W macroemulsions, O / W microemulsions or 0 / W / O emulsions with diketopiperazines of the formula I present in dispersed form are also possible, the emulsions being obtainable by phase inversion technology in accordance with DE-A-197 26 121 ,
  • Typical cosmetic auxiliaries which can be considered as additives are, for example, co-emulsifiers, fats and waxes, stabilizers, thickeners, biogenic active substances, film formers, fragrances, dyes, pearlescent agents, preservatives, pigments, electrolytes (for example magnesium sulfate) and pH - regulators.
  • Known W / O and, in addition, also O / W emulsifiers such as polyglycerol esters, sorbitan esters or partially esterified glycerides are preferred as co-emulsifiers.
  • Typical examples of fats are glycerides; waxes include beeswax, paraffin wax or microwaxes, optionally in combination with hydrophilic waxes.
  • Suitable thickeners are, for example, crosslinked polyacrylic acids and their derivatives, polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also fatty alcohols, monoglycerides and fatty acids, polycrylates, polyvinyl alcohol and polyvinyl pyrrolidone.
  • Biogenic active substances are understood to mean, for example, plant extracts, protein hydrolyzates and vitamin complexes.
  • Common film formers are, for example, hydrocolloids such as chitosan, microcrystalline chitosan or guater nated chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives and similar compounds.
  • Suitable preservatives are, for example, formaldehyde solution, p-hydroxybenzoate or sorbic acid.
  • Suitable pearlizing agents are, for example, glycol distearic acid esters such as ethylene glycol distearate, but also fatty acids and fatty acid monoglycol esters.
  • Dyes which can be used are the substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Colorants” by the Dye Commission of the German Research Foundation, published by Verlag Chemie, Weinheim, 1984. These dyes are usually used in a concentration of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • antioxidants are generally preferred. All of the antioxidants suitable or customary for cosmetic and / or dermatological applications can be used as favorable antioxidants.
  • the antioxidants are advantageously selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (eg anserine), carotenoids, carotenes (eg ⁇ -carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and their derivatives (eg dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (eg thiorodoxin, glutathione) , Cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl, and lauryl, palmitoyl, oley
  • chelators e.g. ⁇ -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), ⁇ -hydroxy acids (e.g. citric acid, lactic acid, malic acid), Humic acid, bile acid, bile extracts, biliburin, biliverdin, EDTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. ⁇ -linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and their derivatives (e.g.
  • Ascorbyl palmitate Mg ascorbyl phosphate, ascorbyl acetate), tocopherol and derivatives (eg vitamin E acetate, tocotrienol), vitamin A and Derivatives (vitamin A palmitate) as well as coniferyl benzoate of benzoin, rutinic acid and its derivatives, ⁇ -glycosyl rutin, ferulic acid, furfurylidene glucitol, carnosine, butylated hydroxytoluene, butylated hydroxyanisole, nordihydroguajak resin acid, nordihydroguoyihydroxyne derivatives, and their derivatives , Mannose and its derivatives, zinc and its derivatives (eg ZnO, ZnS0 4 ), selenium and its derivatives (eg selenium methionine), stilbenes and their derivatives (eg stilbene oxide, trans-stilbene oxide).
  • benzoin rutinic acid and its derivatives
  • the amount of the aforementioned antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 1 to 10% by weight, based on the total weight of the Preparation.
  • vitamin E and / or its derivatives represent the antioxidant (s)
  • vitamin A and / or its derivatives or carotenoids represent the antioxidant (s)
  • Typical oil components in cosmetics are, for example, paraffin oil, glyceryl stearate, isopropyl myristate, diisopropyl adipate, 2-ethylhexanoic acid cetyl stearyl ester, hydrogenated polyisobutene, petrolatum, caprylic acid / capric acid triglycerides, microcrystalline wax, lanolin and stearic acid.
  • the total proportion of auxiliaries and additives can be 1 to 80, preferably 6 to 40% by weight and the non-aqueous proportion ("active substance") 20 to 80, preferably 30 to 70% by weight, based on the composition.
  • the preparation of the agents can be carried out in a manner known per se, i.e. for example by hot, cold, hot-hot / cold or PIT emulsification. This is a purely mechanical process, there is no chemical reaction.
  • Such sunscreen preparations can accordingly be in liquid, pasty or solid form, for example as water-in-oil creams, oil-in-water creams and lotions, aerosol foam creams, gels, oils, grease pencils, powders, sprays or alcoholic-aqueous lotions ,
  • other substances which are known per se in the UV range can also be used, provided they are stable in the overall system of the combination of UV filters to be used according to the invention.
  • Most of the light stabilizers in the cosmetic and pharmaceutical preparations used to protect the human epidermis consist of compounds which absorb UV light in the UV-B range, i.e. in the range from 280 to 320 nm.
  • the proportion of UV-A absorbers to be used according to the invention is 10 to 90% by weight, preferably 20 to 50% by weight, based on the total amount of UV-B and UV-A absorbents substances.
  • UV-A and UV-B filter substances are suitable as UV filter substances which are used in combination with the compounds of formula I to be used according to the invention. Examples include:
  • the cosmetic and dermatological preparations according to the invention can advantageously also contain inorganic pigments based on metal oxides and / or other metal compounds which are sparingly soluble or insoluble in water, in particular the oxides of titanium (Ti0 2 ), zinc (ZnO), iron (eg Fe0 3 ), zirconium ( Zr0), silicon (Si0), manganese (eg MnO), aluminum (Al0 3 ), cerium (eg Ce0 3 ), mixed oxides of the corresponding metals and mixtures of such oxides. Pigments based on TiO 2 and ZnO are particularly preferred.
  • the inorganic pigments are present in hydrophobic form, ie that they have been treated to be water-repellent on the surface.
  • This surface treatment can consist of the pigments being processed in a manner known per se, as in DE-A-33 14 742 described, are provided with a thin hydrophobic layer.
  • the light stabilizers of the formula I according to the invention can be used in shampoos, lotions, gels, hair sprays, aerosol foam creams or emulsions in concentrations of 0.1 to 10% by weight, preferably 1 to 7% by weight be incorporated.
  • the respective formulations can include can be used for washing, dyeing and styling the hair.
  • the compounds to be used according to the invention are generally distinguished by a particularly high absorption capacity in the UV-A radiation range with a sharp band structure. Furthermore, they are readily soluble in cosmetic oils and can be easily incorporated into cosmetic formulations.
  • the emulsions prepared with the compounds I are particularly notable for their high stability, the compounds I themselves are distinguished by their high photostability, and the preparations prepared with I are notable for their pleasant skin feel.
  • UV filter action of the compounds of the formula I according to the invention can also be used to stabilize active ingredients and auxiliaries in cosmetic and pharmaceutical formulations.
  • the compounds ac were prepared analogously to the synthesis described in EP 65 5 060.
  • the piperazines were obtained from the reaction of 1, 4-diacetyl-2, 5-piperazinedione with corresponding benzaldehydes in the presence of triethylamine. Table 1
  • Example 2 Standardized method for determining the photo
  • a 5% by weight alcoholic solution of the light stabilizer to be tested is applied to the milling of a glass plate using an Eppendorf pipette (20 ⁇ l).
  • the alcohol is distributed evenly over the roughened glass surface.
  • the amount applied corresponds to the amount of sunscreen that is required in sunscreens to achieve an average sun protection factor.
  • 4 glass plates are irradiated. The evaporation time and
  • the glass plates are slightly cooled during the irradiation by a water cooling system, which is located on the bottom of the sun tester.
  • the temperature inside the Suntest device is 40 ° C during the irradiation. After the samples have been irradiated, they are used with
  • Example 3 Composition for lip care
  • Example 4 Composition for lip care
  • Example 6 Composition for sun blockers with micropigments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne l'utilisation de dérivés de dicétopipérazines de formule générale (I), dans laquelle les variables ont les significations indiquées dans la description, comme filtres UV photostables dans des préparations cosmétiques et pharmaceutiques pour protéger la peau ou les cheveux contre les rayons du soleil, ces dérivés étant utilisés seuls ou en association avec des composés connus pour préparations cosmétiques et pharmaceutiques absorbant la lumière dans le domaine de l'ultraviolet.
EP03793639A 2002-08-15 2003-07-24 Utilisation de derives de dicetopiperazines comme filtres uv photostables dans des preparations cosmetiques et pharmaceutiques Withdrawn EP1530454A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10238144A DE10238144A1 (de) 2002-08-15 2002-08-15 Verwendung von Diketopiperazin-Derivaten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
DE10238144 2002-08-15
PCT/EP2003/008109 WO2004022015A1 (fr) 2002-08-15 2003-07-24 Utilisation de derives de dicetopiperazines comme filtres uv photostables dans des preparations cosmetiques et pharmaceutiques

Publications (1)

Publication Number Publication Date
EP1530454A1 true EP1530454A1 (fr) 2005-05-18

Family

ID=30775460

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03793639A Withdrawn EP1530454A1 (fr) 2002-08-15 2003-07-24 Utilisation de derives de dicetopiperazines comme filtres uv photostables dans des preparations cosmetiques et pharmaceutiques

Country Status (7)

Country Link
US (1) US20050249681A1 (fr)
EP (1) EP1530454A1 (fr)
JP (1) JP2005539052A (fr)
CN (1) CN1674859A (fr)
AU (1) AU2003266239A1 (fr)
DE (1) DE10238144A1 (fr)
WO (1) WO2004022015A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101632669B (zh) 2000-08-04 2011-05-18 Dmi生物科学公司 二酮基哌嗪和包含它们的组合物的使用方法
JP4674317B2 (ja) * 2002-10-02 2011-04-20 ディエムアイ アクイジション コーポレイション 疾病の判定および監視
DK2537524T3 (en) * 2003-05-15 2016-10-24 Ampio Pharmaceuticals Inc The treatment of T cell mediated diseases
WO2009146320A1 (fr) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Procédés et composés thérapeutiques
EP2153815A1 (fr) 2008-08-05 2010-02-17 Isdin S.A. Utilisation de compositions contenant de l'urée
EP2153814A1 (fr) 2008-08-05 2010-02-17 Isdin S.A. Utilisation de composition comportant de l'urée
CA2810844C (fr) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Compositions de diketopiperazine destinees au traitement de syndrome metabolique et de troubles associes
PL2766029T3 (pl) 2011-10-10 2020-08-24 Ampio Pharmaceuticals, Inc. Leczenie choroby zwyrodnieniowej stawów
JP2014530063A (ja) 2011-10-10 2014-11-17 アンピオ ファーマシューティカルズ，インコーポレイテッド 免疫寛容が高められた埋込み型医療用デバイス、ならびに製造方法および埋込み方法
JP6231484B2 (ja) 2011-10-28 2017-11-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 鼻炎の処置
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CA2958080A1 (fr) 2014-08-18 2016-02-25 Ampio Pharmaceuticals, Inc. Traitement de pathologies articulaires
JP6209289B2 (ja) * 2014-10-22 2017-10-04 サントリーホールディングス株式会社 環状ジペプチドを有効成分とする皮膚保湿機能改善剤
KR101635618B1 (ko) * 2014-12-29 2016-07-08 한국해양대학교 산학협력단 피부노화 억제와 피부주름 개선 활성을 가지는 화합물
WO2016209969A1 (fr) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Utilisation de fractions d'albumine de sérum humain de bas poids moléculaire pour traiter les maladies
FR3062853A1 (fr) * 2017-02-14 2018-08-17 Laboratoire Shigeta Utilisation de 2,5-dicetopiperazines en tant qu’agents cosmetiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3761477A (en) * 1968-11-08 1973-09-25 Mc Neil Labor Inc Pyrazineacetic acids, lower alkyl esters, amides and salts
EP0496434B1 (fr) * 1987-10-22 1999-02-03 The Procter & Gamble Company Compositions photoprotectrices contenant des agents chélatants
DE3918178A1 (de) * 1989-06-03 1990-12-06 Bayer Ag Heterocyclische verbindungen
US5087445A (en) * 1989-09-08 1992-02-11 Richardson-Vicks, Inc. Photoprotection compositions having reduced dermal irritation
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds
DE10013318A1 (de) * 2000-03-17 2001-09-20 Merck Patent Gmbh Formulierung enthaltend Chinoxalinderivate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004022015A1 *

Also Published As

Publication number Publication date
US20050249681A1 (en) 2005-11-10
JP2005539052A (ja) 2005-12-22
CN1674859A (zh) 2005-09-28
DE10238144A1 (de) 2004-02-26
WO2004022015A1 (fr) 2004-03-18
AU2003266239A1 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
EP1046391B1 (fr) Usage d'hydroxybenzophénones aminosubstituées comme filtres UV photostables dans des préparations cosmétiques et pharmaceutiques
DE10012408A1 (de) Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil aminosubstituierte Hydroxybenzophenone enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
DE19855649A1 (de) Dimere alpha-Alkyl-Styrolderivate als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
DE19712033A1 (de) Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
DE10012413A1 (de) Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 4,4'-Diarylbutadiene enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
EP0852137A2 (fr) Compositions cosmétiques contenant un filtre UV-A photostable
DE19746654A1 (de) Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
DE19828463A1 (de) 4,4-Diarylbutadiene als wasserlösliche photostabile UV-Filter für kosmetische und pharmazeutische Zubereitungen
EP0916335A2 (fr) Compositions cosmétiques et pharmaceutiques contenant un filtre UV photostabile
DE19755649A1 (de) Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
EP1530454A1 (fr) Utilisation de derives de dicetopiperazines comme filtres uv photostables dans des preparations cosmetiques et pharmaceutiques
DE10113058A1 (de) Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 2-(4-Alkoxy-anilinomethylen)-malonsäure-dialkylester enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
DE10063946A1 (de) Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 2,2'-p-Phenylen-bis(3,1-benzoxazin-4-on) enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
DE19928033A1 (de) Verwendung von cyclischen Enaminen als Lichtschutzmittel
EP0911020B1 (fr) Dérivés de méthylstyrène comme filtres ultraviolet et compositions cosmétiques et pharmaceutiques les contenant
DE19634229A1 (de) Photostabile UV-A-Filter enthaltende kosmetische Zubereitungen
EP0945125B1 (fr) Compositions cosmétiques et pharmaceutiques contenant des filtres UV photostables
DE19755650A1 (de) Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
DE10009442A1 (de) Kosmetische oder dermatologische Lichtschutzmittelzubereitung
DE19651055B4 (de) Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Triazinderivaten und Dimethylisosorbid und deren Verwendung
DE10063867A1 (de) Kosmetische Lichtschutzzubereitungen
EP1660030A1 (fr) Melange constitue d'un filtre pour uv-a et d'un filtre pour uv-b
DE19540952A1 (de) Photostabile UV-A-Filter enthaltende kosmetische Zubereitungen
DE19649381A1 (de) Photostabile UV-A-Filter enthaltende kosmetische Zubereitungen
DE19719930B4 (de) Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Triazinderivaten und Myristylpropionat sowie deren Verwendung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

17P Request for examination filed

Effective date: 20050315

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

18W Application withdrawn

Effective date: 20050411